Literature DB >> 35146338

A narrative review of emergency use authorization versus full FDA approval and its effect on COVID-19 vaccination hesitancy.

Thoyaja Koritala1, Akbar Hussain2, Yelena Pleshkova3, Lavanya Dondapati4, Raghavendra Tirupathi5, Ali A Rabaan6,7, Abbas Al Mutair8,9,10, Saad Alhumaid11, Jaffar A Al-Tawfiq12,13,14, Rahul Kashyap15.   

Abstract

COVID-19 pandemic affected the lives of many with its devastating mortality and morbidity. Acquisition of herd immunity is one way to mitigate the spread of infection. Many factors influence the acceptance of vaccination including the regulatory process of the vaccines. This review article will briefly summarize the Emergency Use Authorization, Full FDA Approval process and highlight how the key factors affecting the vaccination hesitancy, are being influenced by the lack of Full FDA Approval.
Copyright © 2016 - 2021 InfezMed.

Entities:  

Keywords:  COVID-19; emergency use authorization; full FDA approval; herd immunity; vaccine resistance

Year:  2021        PMID： 35146338      PMCID： PMC8805497          DOI： 10.53854/liim-2903-4

Source DB:  PubMed          Journal:  Infez Med        ISSN： 1124-9390


  14 in total

Review 1.  Emergency Use Authorization (EUA) to enable use of needed products in civilian and military emergencies, United States.

Authors:  Stuart L Nightingale; Joanna M Prasher; Stewart Simonson
Journal:  Emerg Infect Dis       Date:  2007-07       Impact factor: 6.883

2.  Public support for government actions during a flu pandemic: lessons learned from a statewide survey.

Authors:  Hye-Jin Paek; Karen Hilyard; Vicki S Freimuth; J Kevin Barge; Michele Mindlin
Journal:  Health Promot Pract       Date:  2008-10

3.  Rapid COVID-19 vaccine development.

Authors:  Barney S Graham
Journal:  Science       Date:  2020-05-08       Impact factor: 47.728

4.  African Americans' views on research and the Tuskegee Syphilis Study.

Authors:  V S Freimuth; S C Quinn; S B Thomas; G Cole; E Zook; T Duncan
Journal:  Soc Sci Med       Date:  2001-03       Impact factor: 4.634

5.  COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.

Authors:  S A Meo; I A Bukhari; J Akram; A S Meo; D C Klonoff
Journal:  Eur Rev Med Pharmacol Sci       Date:  2021-02       Impact factor: 3.507

6.  Public willingness to take a vaccine or drug under Emergency Use Authorization during the 2009 H1N1 pandemic.

Authors:  Sandra Crouse Quinn; Supriya Kumar; Vicki S Freimuth; Kelley Kidwell; Donald Musa
Journal:  Biosecur Bioterror       Date:  2009-09

7.  Smallpox vaccination: a national survey of emergency health care providers.

Authors:  Worth W Everett; Susan E Coffin; Theoklis Zaoutis; Scott D Halpern; Brian L Strom
Journal:  Acad Emerg Med       Date:  2003-06       Impact factor: 3.451

8.  Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemic.

Authors:  Ioannis Kyrou; Emmanouil Karteris; Tim Robbins; Kamaljit Chatha; Fotios Drenos; Harpal S Randeva
Journal:  BMC Med       Date:  2020-07-15       Impact factor: 8.775

9.  Guide to Understanding the 2019 Novel Coronavirus.

Authors:  Aditya Shah; Rahul Kashyap; Pritish Tosh; Priya Sampathkumar; John C O'Horo
Journal:  Mayo Clin Proc       Date:  2020-02-28       Impact factor: 7.616

10.  Hospitalization of Adolescents Aged 12-17 Years with Laboratory-Confirmed COVID-19 - COVID-NET, 14 States, March 1, 2020-April 24, 2021.

Authors:  Fiona P Havers; Michael Whitaker; Julie L Self; Shua J Chai; Pam Daily Kirley; Nisha B Alden; Breanna Kawasaki; James Meek; Kimberly Yousey-Hindes; Evan J Anderson; Kyle P Openo; Andrew Weigel; Kenzie Teno; Maya L Monroe; Patricia A Ryan; Libby Reeg; Alexander Kohrman; Ruth Lynfield; Kathryn Como-Sabetti; Mayvilynne Poblete; Chelsea McMullen; Alison Muse; Nancy Spina; Nancy M Bennett; Maria Gaitán; Laurie M Billing; Jess Shiltz; Melissa Sutton; Nasreen Abdullah; William Schaffner; H Keipp Talbot; Melanie Crossland; Andrea George; Kadam Patel; Huong Pham; Jennifer Milucky; Onika Anglin; Dawud Ujamaa; Aron J Hall; Shikha Garg; Christopher A Taylor
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2021-06-11       Impact factor: 17.586
View more
  9 in total

Review 1.  A review of adverse effects of COVID-19 vaccines.

Authors:  Hisham Ahmed Mushtaq; Anwar Khedr; Thoyaja Koritala; Brian N Bartlett; Nitesh K Jain; Syed Anjum Khan
Journal:  Infez Med       Date:  2022-03-01

2.  First Report of Acute Myocarditis Post-Pfizer-BioNTech COVID-19 Vaccination in the Kingdom of Bahrain.

Authors:  Tarique S Chachar; Nooraldaem Yousuf; Leena Sulaibikh; Fuad Abdulqader; Manaf Alqahtani
Journal:  Cureus       Date:  2021-12-09

3.  Post-COVID-19 syndrome: assessment of short- and long-term post-recovery symptoms in recovered cases in Saudi Arabia.

Authors:  Mohammed A Garout; Saleh A K Saleh; Heba M Adly; Altaf A Abdulkhaliq; Abdullah A Khafagy; Magda R Abdeltawab; Ali A Rabaan; Alfonso J Rodriguez-Morales; Jaffar A Al-Tawfiq; Maher N Alandiyjany
Journal:  Infection       Date:  2022-03-16       Impact factor: 7.455

4.  Overview of clinical outcome and therapeutic effectiveness of Favipiravir in patients with COVID-19 admitted to intensive care unit, Riyadh, Saudi Arabia.

Authors:  Abbas Al Mutair; Jinan Shamou; Saad Alhumaid; Laila Layqah; Gasmelseed Y Ahmed; Koritala Thoyaja; Mohammed Al Mohaini; Sana Almahmoud; Mazin Barry; Amjad Khan; Kuldeep Dhama; Lamiaa Hamad Al-Jamea; Alxeander Woodman; Ali A Rabaan
Journal:  J Infect Public Health       Date:  2022-02-15       Impact factor: 3.718

5.  Safety, tolerability, and antibody response after intradermal vaccination of PFE-BNT in adults who have completed two-doses of Verocell (inactivated vaccine).

Authors:  Nipon Chalermphanchai; Wachiraporn Arunothong; Niphawan Jettavan; Surin Chanta; Thunthiwa Boonpisitsakul; Monthon Mayoon; Piyawan Lueangchiranothai; Natthawat Yodsurang; Wichai Chanchue; Yupin Tananuchit; Kullaya Jangaroon; Waroonkarn Meungsuwan; Thantima Nantawong
Journal:  Vaccine X       Date:  2022-02-22

6.  Guillain-Barré/Miller Fisher overlap syndrome in a patient after coronavirus disease-2019 infection: a case report.

Authors:  Seyede Momeneh Mohammadi; Roghayeh Abdi; Zeinab Karimi; Fatemeh Mortazavi
Journal:  J Med Case Rep       Date:  2022-02-08

7.  Coronavirus disease 2019 presenting as psychosis: a case report.

Authors:  Nyanyuie Kodjo Lovi; Selase Kofi Kekrebesi; Mary Osei; Eugene Yeboah
Journal:  J Med Case Rep       Date:  2022-04-22

8.  Why do people consent to receiving SARS-CoV-2 vaccinations? A representative survey in Germany.

Authors:  Harald Walach; Michael Ofner; Viviane Ruof; Markus Herbig; Rainer Johannes Klement
Journal:  BMJ Open       Date:  2022-08-18       Impact factor: 3.006

9.  Prone position protocol in awake COVID-19 patients: A prospective study in the emergency department.

Authors:  Saqer Althunayyan; Abdulaziz M Almutary; Mohammad Asim Junaidallah; Anas Saleh Heji; Faisal Almazroua; Yousef M Alsofayan; Ahmed Al-Wathinani; Yazed AlRuthia
Journal:  J Infect Public Health       Date:  2022-02-22       Impact factor: 7.537
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.